THE NHLBI MODEL - A 25 YEAR HISTORY

被引:14
作者
FRIEDMAN, L
机构
[1] National Heart, Blood Institute, Bethesda, Maryland, 20892
关键词
D O I
10.1002/sim.4780120505
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although newer techniques and procedures have been developed, many of the clinical trial design and monitoring concepts used today in the NHLBI were implemented 25 years ago. Among these are the organizational structure of multicentre trials and the use of an independent data monitoring committee. Examples of data monitoring committee discussions and decisions are provided.
引用
收藏
页码:425 / 431
页数:7
相关论文
共 16 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[3]   THE EVENTS SURROUNDING THE REMOVAL OF ENCAINIDE AND FLECAINIDE FROM THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) AND WHY CAST IS CONTINUING WITH MORICIZINE [J].
BIGGER, JT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (01) :243-245
[4]   MONITORING OF THE DATA FOR EVIDENCE OF ADVERSE OR BENEFICIAL TREATMENT EFFECTS [J].
CANNER, PL .
CONTROLLED CLINICAL TRIALS, 1983, 4 (04) :467-483
[5]  
CANNER PL, CORONARY DRUG PROJEC
[6]   STATISTICAL ASPECTS OF EARLY TERMINATION IN THE BETA-BLOCKER HEART ATTACK TRIAL [J].
DEMETS, DL ;
HARDY, R ;
FRIEDMAN, LM ;
LAN, KKG .
CONTROLLED CLINICAL TRIALS, 1984, 5 (04) :362-372
[7]  
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
[8]  
NICKLAS JM, 1992, NEW ENGL J MED, V327, P685
[9]  
The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652